BIBI , N. and MALIK , M. (2025) “ COMPARISON OF 550MG/DAY VERSES 1100 MG/DAY RIFAXIMIN IN SECONDARY PREVENTION OF BOTH COVERT AND OVERT HEPATIC ENCEPHALOPATHY”, Pakistan Journal of Intensive Care Medicine, 5(01), p. 71. doi: 10.54112/pjicm.v5i01.71.